Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identifying thresholds for meaningful improvements in NTDT-PRO scores to support conclusions about treatment benefit in clinical studies of patients with non-transfusion-dependent beta-thalassaemia: analysis of pooled data from a phase 2, double-blind, placebo-controlled, randomised trial.
Taher AT, Musallam KM, Viprakasit V, Kattamis A, Lord-Bessen J, Yucel A, Guo S, Pelligra CG, Shields AL, Shetty JK, Glassberg MB, Bueno LM, Cappellini MD. Taher AT, et al. Among authors: pelligra cg. BMJ Open. 2024 Nov 14;14(11):e085234. doi: 10.1136/bmjopen-2024-085234. BMJ Open. 2024. PMID: 39542473 Free PMC article. Clinical Trial.
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis.
Gossec L, Orbai AM, Coates LC, Gladman DD, Ogdie A, Pelligra CG, Ciaravino V, Ink B, Taieb V, Lambert J, de Wit M. Gossec L, et al. Among authors: pelligra cg. RMD Open. 2024 Jan 31;10(1):e003548. doi: 10.1136/rmdopen-2023-003548. RMD Open. 2024. PMID: 38296802 Free PMC article.
Calibration and validation of modeled 5-year survival predictions among people with cystic fibrosis treated with the cystic fibrosis transmembrane conductance regulator modulator ivacaftor using United States registry data.
McGarry LJ, Bhaiwala Z, Lopez A, Chandler C, Pelligra CG, Rubin JL, Liou TG. McGarry LJ, et al. Among authors: pelligra cg. PLoS One. 2023 Apr 12;18(4):e0283479. doi: 10.1371/journal.pone.0283479. eCollection 2023. PLoS One. 2023. PMID: 37043485 Free PMC article.
Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic Syndromes.
Santini V, Giagounidis A, Pelligra CG, Franco-Villalobos C, Tang D, Morison J, Beach CL, Hu A, Platzbecker U, Fenaux P. Santini V, et al. Among authors: pelligra cg. Clin Lymphoma Myeloma Leuk. 2022 Sep;22(9):e874-e883. doi: 10.1016/j.clml.2022.05.001. Epub 2022 May 21. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35710702 Free article.
Cost-effectiveness of lenalidomide plus dexamethasone vs. bortezomib plus melphalan and prednisone in transplant-ineligible U.S. patients with newly-diagnosed multiple myeloma.
Usmani SZ, Cavenagh JD, Belch AR, Hulin C, Basu S, White D, Nooka A, Ervin-Haynes A, Yiu W, Nagarwala Y, Berger A, Pelligra CG, Guo S, Binder G, Gibson CJ, Facon T. Usmani SZ, et al. Among authors: pelligra cg. J Med Econ. 2016;19(3):243-58. doi: 10.3111/13696998.2015.1115407. Epub 2015 Nov 17. J Med Econ. 2016. PMID: 26517601 Free article.